Skip to main content
Clinical Trials/NL-OMON40446
NL-OMON40446
Completed
Not Applicable

Discovery of tumor markers through platelet proteomics - Platelet tumor markers

Medisch Universitair Ziekenhuis Maastricht0 sites44 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
44
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • \-Patients with stage I\&II lung and pancreatic malignancies who are eligible for surgical resection.
  • \-Age \>18 years
  • \-Histologically confirmed adenocarcinoma
  • \-Hb \>5\.6 mmol/L

Exclusion Criteria

  • \-Use of any platelet\-influencing drug during two weeks prior to blood collection
  • \-Patients with congenital platelet disorder
  • \-Blood or platelet transfusion during two weeks prior to blood collection
  • \-Inflammatory diseases or diabetes
  • \-Serious non\-healing wound, ulcer, or bone fracture
  • \-Pregnancy or breast\-feeding
  • \-Interference with other research projects

Outcomes

Primary Outcomes

Not specified

Similar Trials